Cephalon (CEPH) To Acquire Gemin X Pharma in $225M Deal; $300M in Milestones Possible
Tweet Send to a Friend
Cephalon, Inc. (Nasdaq: CEPH) has signed a definitive merger agreement under which it will acquire all of the outstanding capital ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


